Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC-ND 4.0Nature Communications

Ethnicity, genomic ancestry, and HBV genotype in off-treatment outcomes following nucleos(t)ide analogue cessation: a prospective multicentre trial (COIN-B)

17 more authors

Related

  1. Predictability of symptom changes following hemithyroidectomy due to compression symptoms assessed by specific questionnaires: prospective multicentre study.
    Ervin Beka, Ivan Shabo, David Fornander +2
    BJS openPeer-reviewedCC BY-NCFull textSurgery & anaesthesiaEurope PMC
  2. Causal discovery and treatment effect heterogeneity of futile recanalisation (CADISTH) for large vessel occlusion stroke: protocol and rationale for a multicentre prospective cohort study
    Zuting Liu, Tian Luo, Min Yin +12
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textEpidemiology & public healthCrossref
  3. Imaging-guided shortened interpregnancy interval following myomectomy in China: protocol for a multicentre prospective randomised controlled trial
    Yiran Han, Chenfeng Zhu, Jun Zhang +4
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textObstetrics, gynaecology & paediatricsCrossref
  4. Interstitial Lung Diseases treatment prescription practices among pulmonologists in India: A prospective multicentre observational study (India-ILD care study).
    Vijay Hadda, Avishek Layek, Pawan Tiwari +33
    PloS onePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Clinical outcomes following five-day accelerated intermittent theta burst stimulation for treatment-resistant depression in routine clinical practice: A prospective naturalistic cohort study
    Asmi Khanna, Adrian Espiritu, Lynn Zhu +7
    CNS SpectrumsPeer-reviewedCC BY 4.0Full textNeurologyPMC
BibTeX
@article{dalmeida2026ethnicity,
  title = {{Ethnicity, genomic ancestry, and HBV genotype in off-treatment outcomes following nucleos(t)ide analogue cessation: a prospective multicentre trial (COIN-B)}},
  author = {Arno Furquim d’Almeida and Axelle Vanderlinden and Arwin Ralf and Stefan Bourgeois and Jean-Pierre Mulkay and Thomas Sersté and Mathieu Struyve and Baro Deressa and Dirk Sprengers and Marie de Vos and Jos Callens and Bao Shihao and Silke François and Pierre Deltenre and Filip Janssens and Sergio Negrin Dastis and Peter Stärkel and Hans Orlent and Guy Van Roey and Xavier Verhelst and Christophe Moreno and Jean Delwaide and Christophe Van Steenkiste and Wim Verlinden and Isabelle Colle and Manfred Kayser and Benoît Kabamba Mukadi and Veerle Matheeussen and Thomas Vanwolleghem},
  journal = {Nature Communications},
  year = {2026},
  month = oct,
  doi = {10.1038/s41467-026-78490-0},
  url = {https://www.nature.com/articles/s41467-026-78490-0},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Ethnicity, genomic ancestry, and HBV genotype in off-treatment outcomes following nucleos(t)ide analogue cessation: a prospective multicentre trial (COIN-B)
AU  - Arno Furquim d’Almeida
AU  - Axelle Vanderlinden
AU  - Arwin Ralf
AU  - Stefan Bourgeois
AU  - Jean-Pierre Mulkay
AU  - Thomas Sersté
AU  - Mathieu Struyve
AU  - Baro Deressa
AU  - Dirk Sprengers
AU  - Marie de Vos
AU  - Jos Callens
AU  - Bao Shihao
AU  - Silke François
AU  - Pierre Deltenre
AU  - Filip Janssens
AU  - Sergio Negrin Dastis
AU  - Peter Stärkel
AU  - Hans Orlent
AU  - Guy Van Roey
AU  - Xavier Verhelst
AU  - Christophe Moreno
AU  - Jean Delwaide
AU  - Christophe Van Steenkiste
AU  - Wim Verlinden
AU  - Isabelle Colle
AU  - Manfred Kayser
AU  - Benoît Kabamba Mukadi
AU  - Veerle Matheeussen
AU  - Thomas Vanwolleghem
PY  - 2026
DA  - 2026/10/08
JO  - Nature Communications
DO  - 10.1038/s41467-026-78490-0
UR  - https://www.nature.com/articles/s41467-026-78490-0
SN  - 2041-1723
ER  -